Pervasive sign epistasis between conjugative plasmids and Drug-Resistance chromosomal mutations

PLoS Genetics

Volumn 7, Issue 7, 2011, Pages

  Silva, Rui F ^a,b   MendonçaSí, Sílvia C M ^a,b   CarvalhoLuí, Luís M ^a,b   Reis, Ana M ^a   Gordo, Isabel ^b   Trindade, Sandra ^a,b   Dionisio, Francisco ^a,b  

^a UNIVERSITY OF LISBON   (Portugal)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

NALIDIXIC ACID; RIFAMPICIN; STREPTOMYCIN; ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIAL STRAIN; CHROMOSOME ANALYSIS; CHROMOSOME MUTATION; CONTROLLED STUDY; DRUG USE; ESCHERICHIA COLI; GENE INTERACTION; GENETIC EPISTASIS; GYRA GENE; HETEROZYGOTE; MUTATIONAL ANALYSIS; NONHUMAN; NULL ALLELE; PLASMID; RPOB GENE; RPSL GENE; BACTERIAL CHROMOSOME; BACTERIUM CONJUGATION; DRUG EFFECT; GENETICS; MUTATION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; CHROMOSOMES, BACTERIAL; CONJUGATION, GENETIC; DRUG RESISTANCE, BACTERIAL; EPISTASIS, GENETIC; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; MUTATION; PLASMIDS;

EID: 79960959549     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002181     Document Type: Article

References (59)

1. Martinez JL, Fajardo A, Garmendia L, Hernandez A, Linares JF, et al. (2009) A global view of antibiotic resistance. FEMS Microbiol Rev 33: 44-65.
2. Bertino JS, (2009) Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clin Ophthalmol 3: 507-521.
3. Andersson DI, Levin BR, (1999) The biological cost of antibiotic resistance. Curr Opin Microbiol 2: 489-493.
4. Andersson DI, (2006) The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 9: 461-465.
5. Lenski RE, (1998) Bacterial evolution and the cost of antibiotic resistance. Int Microbiol 1: 265-270.
6. Nilsson AI, Berg OG, Aspevall O, Kahlmeter G, Andersson DI, (2003) Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother 47: 2850-2858.
7. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, et al. (1997) The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 337: 441-446.
8. Enne VI, Livermore DM, Stephens P, Hall LM, (2001) Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 357: 1325-1328.
9. Schrag SJ, Perrot V, (1996) Reducing antibiotic resistance. Nature 381: 120-121.
10. Schrag SJ, Perrot V, Levin BR, (1997) Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc R Soc B 264: 1287-1291.
11. Maisnier-Patin S, Berg OG, Liljas L, Andersson DI, (2002) Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium. Mol Microbiol 46: 355-366.
12. Bjorkman J, Nagaev I, Berg OG, Hughes D, Andersson DI, (2000) Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287: 1479-1482.
13. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, et al. (2006) The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312: 1944-1946.
14. Trzcinski K, Thompson CM, Gilbey AM, Dowson CG, Lipsitch M, (2006) Incremental increase in fitness cost with increased beta-lactam resistance in pneumococci evaluated by competition in an infant rat nasal colonization model. J Infect Dis 193: 1296-1303.
15. Orio AGA, Pinas GE, Cortes PR, Cian MB, Echenique J, (2011) Compensatory Evolution of pbp Mutations Restores the Fitness Cost Imposed by beta-Lactam Resistance in Streptococcus pneumoniae. PLoS Path 7: e1002000 doi:10.1371/journal.ppat.1002000.
16. Denamur E, Lecointre G, Darlu P, Tenaillon O, Acquaviva C, et al. (2000) Evolutionary implications of the frequent horizontal transfer of mismatch repair genes. Cell 103: 711-721.
17. Boucher Y, Douady CJ, Papke RT, Walsh DA, Boudreau ME, et al. (2003) Lateral gene transfer and the origins of prokaryotic groups. Annu Rev Genet 37: 283-328.
18. Cohen O, Pupko T, (2009) Inference and Characterization of Horizontally Transferred Gene Families using Stochastic Mapping. Mol Biol Evol 27: 703-713.
19. Dionisio F, Matic I, Radman M, Rodrigues OR, Taddei F, (2002) Plasmids spread very fast in heterogeneous bacterial communities. Genetics 162: 1525-1532.
20. Amábile-Cuevas CF, Chicurel ME, (1992) Bacterial Plasmids and Gene Flux. Cell 70: 189-199.
21. Bennett PM, (2008) Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br J Pharmacol 153 (Suppl 1): S347-357.
22. Bouma JE, Lenski RE, (1988) Evolution of a Bacteria Plasmid Association. Nature 335: 351-352.
23. McDermott PJ, Gowland P, Gowland PC, (1993) Adaptation of Escherichia coli growth rates to the presence of pBR322. Lett Appl Microbiol 17: 139-143.
24. Smith MA, Bidochka MJ, (1998) Bacterial fitness and plasmid loss: the importance of culture conditions and plasmid size. Can J Microbiol 44: 351-355.
25. Dahlberg C, Chao L, (2003) Amelioration of the cost of conjugative plasmid carriage in Eschericha coli K12. Genetics 165: 1641-1649.
26. Dionisio F, Conceicao IC, Marques AC, Fernandes L, Gordo I, (2005) The evolution of a conjugative plasmid and its ability to increase bacterial fitness. Biol Lett 1: 250-252.
27. Trindade S, Sousa A, Xavier KB, Dionisio F, Ferreira MG, et al. (2009) Positive Epistasis Drives the Acquisition of Multidrug Resistance. PLoS Genet 5: e1000578 doi:10.1371/journal.pgen.1000578.
28. Phillips PC, (2008) Epistasis--the essential role of gene interactions in the structure and evolution of genetic systems. Nat Rev Genet 9: 855-867.
29. Silander OK, Tenaillon O, Chao L, (2007) Understanding the evolutionary fate of finite populations: the dynamics of mutational effects. PLoS Biol 5: e94 10.1371/journal.pbio.0050094.
30. Parera M, Fernandez G, Clotet B, Martinez MA, (2007) HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions. Mol Biol Evol 24: 382-387.
31. Burch CL, Chao L, (2004) Epistasis and its relationship to canalization in the RNA virus phi 6. Genetics 167: 559-567.
32. Maisnier-Patin S, Roth JR, Fredriksson A, Nystrom T, Berg OG, et al. (2005) Genomic buffering mitigates the effects of deleterious mutations in bacteria. Nat Genet 37: 1376-1379.
33. Jasnos L, Korona R, (2007) Epistatic buffering of fitness loss in yeast double deletion strains. Nat Genet 39: 550-554.
34. van Opijnen T, Boerlijst MC, Berkhout B, (2006) Effects of random mutations in the human immunodeficiency virus type 1 transcriptional promoter on viral fitness in different host cell environments. J Virol 80: 6678-6685.
35. Elena SF, (1999) Little evidence for synergism among deleterious mutations in a nonsegmented RNA virus. J Mol Evol 49: 703-707.
36. Crotty S, Cameron CE, Andino R, (2001) RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A 98: 6895-6900.
37. Sanjuan R, Moya A, Elena SF, (2004) The contribution of epistasis to the architecture of fitness in an RNA virus. Proc Natl Acad Sci U S A 101: 15376-15379.
38. Elena SF, Lenski RE, (1997) Test of synergistic interactions among deleterious mutations in bacteria. Nature 390: 395-398.
39. Wilke CO, Adami C, (2001) Interaction between directional epistasis and average mutational effects. Proc Biol Sci 268: 1469-1474.
40. MacLean RC, (2010) Predicting epistasis: an experimental test of metabolic control theory with bacterial transcription and translation. J Evol Biol 23: 488-493.
41. Carneiro M, Hartl DL, (2010) Adaptive landscapes and protein evolution. Proc Natl Acad Sci U S A 107 (Suppl 1): 1747-1751.
42. Casjens S, Palmer N, van Vugt R, Huang WM, Stevenson B, et al. (2000) A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 35: 490-516.
43. San Millan A, Escudero JA, Gutierrez B, Hidalgo L, Garcia N, et al. (2009) Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids. Antimicrob Agents Chemother 53: 3399-3404.
44. Ward H, Perron GG, Maclean RC, (2009) The cost of multiple drug resistance in Pseudomonas aeruginosa. J Evol Biol 22: 997-1003.
45. Rozen DE, Mcgee L, Levin BR, Klugman KP, (2007) Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 51: 412-416.
46. Weinreich DM, Watson RA, Chao L, (2005) Perspective: Sign epistasis and genetic constraint on evolutionary trajectories. Evolution 59: 1165-1174.
47. Harr B, Schlotterer C, (2006) Gene expression analysis indicates extensive genotype-specific crosstalk between the conjugative F-plasmid and the E. coli chromosome. BMC Microbiol 6: 80.
48. Fisher RF, Yanofsky C, (1983) Mutations of the Beta-Subunit of Rna-Polymerase Alter Both Transcription Pausing and Transcription Termination in the Trp Operon Leader Region Invitro. J Biol Chem 258: 8146-8150.
49. Drlica K, Franco RJ, Steck TR, (1988) Rifampin and Rpob Mutations Can Alter DNA Supercoiling in Escherichia-Coli. J Bacteriol 170: 4983-4985.
50. Jin DJ, Gross CA, (1989) Characterization of the Pleiotropic Phenotypes of Rifampin-Resistant Rpob Mutants of Escherichia-Coli. J Bacteriol 171: 5229-5231.
51. Zengel JM, Young R, Dennis PP, Nomura M, (1977) Role of Ribosomal Protein-S12 in Peptide Chain Elongation- Analysis of Pleiotropic, Streptomycin-Resistant Mutants of Escherichia-Coli. J Bacteriol 129: 1320-1329.
52. Jeong KS, Xie Y, Hiasa H, Khodursky AB, (2006) Analysis of pleiotropic transcriptional profiles: A case study of DNA gyrase inhibition. PLoS Genet 2: e152 doi:10.1371/journal.pgen.0020152.
53. Schmitt CK, Kemp P, Molineux IJ, (1995) Streptomycin- and Rifampin-Resistant Mutants of Escherichia-Coli Perturb F-Exclusion of Bacteriophage-T7 by Affecting Synthesis of the F-Plasmid Protein Pifa. J Bacteriol 177: 1589-1594.
54. Ozawa Y, De Boever EH, Clewell DB, (2005) Enterococcus faecalis sex pheromone plasmid pAM373: Analyses of TraA and evidence for its interaction with RpoB. Plasmid 54: 57-69.
55. Wolfson JS, Hooper DC, Swartz MN, Mchugh GL, (1982) Antagonism of the B-Subunit of DNA Gyrase Eliminates Plasmid-Pbr322 and Plasmid-Pmg110 from Escherichia-Coli. J Bacteriol 152: 338-344.
56. He X, Qian W, Wang Z, Li Y, Zhang J, (2010) Prevalent positive epistasis in Escherichia coli and Saccharomyces cerevisiae metabolic networks. Nat Genet 42: 272-276.
57. Norman A, Hansen LH, Sorensen SJ, (2009) Conjugative plasmids: vessels of the communal gene pool. Philos Trans R Soc Lond B Biol Sci 364: 2275-2289.
58. Williams JJ, Hergenrother PJ, (2008) Exposing plasmids as the Achilles' heel of drug-resistant bacteria. Curr Opin Chem Biol 12: 389-399.
59. Lenski RE, Rose MR, Simpson SC, Tadler SC, (1991) Long-term Experimental Evolution in Escherichia coli. I. Adaptation and divergence during 2,000 generations. Am Nat 138: 1315- 1341.